In vitro activity of lumefantrine (Benflumetol) against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 9, 1998, Pages 2347-2351

  Basco, Leonardo K ^a   Bickii, Jean ^a   Ringwald, Pascal ^a,b  

^a Inst Francais Rech Devmt en Coop   (Cameroon)

^b Institut de Recherche pour le Developpement Cameroon   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOALCOHOL; ARTESUNATE; CHINESE DRUG; DEETHYLAMODIAQUINE; FLUORENE DERIVATIVE; HALOFANTRINE; LUMEFRANTINE; MEFLOQUINE; PYRIMETHAMINE; QUININE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; CROSS RESISTANCE; DRUG ACTIVITY; DRUG SENSITIVITY; DRUG STRUCTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

EID: 0031711884     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.9.2347     Document Type: Article

References (36)

1. Basco, L. K., and J. Le Bras. 1992. In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 47:521-527.
2. Basco, L. K., and J. Le Bras. 1992. In vitro activity of pyronaridine against African strains of Plasmodium falciparum. Ann. Trop. Med. Parasitol. 86: 447-454.
3. Basco, L. K., and J. Le Bras. 1993. In vitro activities of monodesethylamo-diaquine and amopyroquine against African isolates and clones of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 48:120-125.
4. Basco, L. K., and J. Le Bras. 1993. In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 49:301-307.
5. Basco, L. K., O. Ramiliarisoa, and J. Le Bras. 1994. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 50: 193-199.
6. Basco, L. K., O. Ramiliarisoa, and J. Le Bras. 1995. In vitro activity of atovaquone (566C80) against the African isolates and clones of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 53:388-391.
7. Bickii, J., L. K. Basco, and P. Ringwald. 1998. Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates. J. Clin. Microbiol. 36:243-247.
8. Bindschedler, M., et al. 1996. XIVth International Congress for Tropical Medicine and Malaria, 17 to 22 November 1996, Nagasaki, Japan, abstr. P-01-96.
9. Bouchaud, O., L. K. Basco, C. Gillotin, F. Gimenez, O. Ramiliarisoa, B. Genissel, E. Bouvet, R. Farinotti, J. Le Bras, and J. P. Coulaud. 1994. Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients. Am. J. Trop. Med. Hyg. 51:204-213.
10. Brewer, T. G., S. J. Grate, J. O. Peggins, P. J. Weina, J. M. Petras, B. S. Levine, M. H. Heiffer, and B. G. Schuster. 1994. Fatal neurotoxicity of arteether and artemether. Am. J. Trop. Med. Hyg. 51:251-259.
11. Brossi, A., B. Venugopalan, L. D. Gerpe, H. J. C. Yeh, J. L. Flippen-Anderson, P. Buchs, X. D. Luo, W. Milhous, and W. Peters. 1988. Arteether, a new antimalarial drug: synthesis and antimalarial properties. J. Med. Chem. 31: 645-650.
12. Canfield, C. J., M. Pudney, and W. E. Gutteridge. 1995. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp. Parasitol. 80:373-381.
13. Chen, C., L. H. Tang, and C. Jantanavivat. 1992. Studies on a new antimalarial compound: pyronaridine. Trans. R. Soc. Trop. Med. Hyg. 86:7-10.
14. Chien, P. L., and C. C. Cheng. 1976. Difference in antimalarial activity between certain amino alcohol diastereomers. J. Med. Chem. 19:170-172.
15. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
16. Fu, S., and S. H. Xiao. 1991. Pyronaridine: a new antimalarial drug. Parasitol. Today 7:310-313.
17. Hien, T. T., and N. J. White. 1993. Qinghaosu. Lancet 341:603-608.
18. Hudson, A. T. 1993. Atovaquone - a novel broad-spectrum anti-infective drug. Parasitol. Today 9:66-68.
19. Karle, J. M., and I. L. Karle. 1991. Crystal structure and molecular structure of mefloquine methylsulfonate monohydrate: implications for a malaria receptor. Antimicrob. Agents Chemother. 35:2238-2245.
20. Looareesuwan, S., D. E. Kyle, C. Viravan, S. Vanijanonta, P. Wilairatana, and W. H. Wernsdorfer. 1996. Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. Am. J. Trop. Med. Hyg. 54:205-209.
21. Mount, D. L., B. L. Nahlen, L. C. Patchen, and F. C. Churchill. 1989. Adaptations of the Saker-Solomons test: simple, reliable colorimetric field assays for chloroquine and its metabolites in urine. Bull. W. H. O. 67:295-300.
22. Nosten, F., F. Ter Kuile, T. Chongsuphajaisiddhi, C. Luxemburger, H. K. Webster, M. Edstein, L. Phaipun, K. L. Thew, and N. J. White. 1991. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 337:1140-1143.
23. Nosten, F., F. O. Ter Kuile, C. Luxemburger. C. Woodrow, D. E. Kyle, T. Chongsuphajaisiddhi, and N. J. White. 1993. Cardiac effects of antimalarial treatment with halofantrine. Lancet 341:1054-1056.
24. Olliaro, P. L., and P. I. Trigg. 1995. Status of antimalarial drugs under development. Bull. W. H. O. 73:565-571.
25. Petras, J. M., D. E. Kyle, M. Gettayacamin, G. D. Young, R. A. Bauman, H. K. Webster, K. D. Corcoran, J. O. Peggins, M. A. Vane, and T. G. Brewer. 1997. Arteether: risks of two-week administration in Macaca mulatta. Am. J. Trop. Med. Hyg. 56:390-396.
26. Radloff, P. D., J. Philipps, M. Nkeyi, D. Hutchinson, and P. G. Kremsner. 1996. Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 347:1511-1514.
27. Ringwald, P., J. Bickii, and L. Basco. 1996. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 347:24-28.
28. Ringwald, P., J. Bickii, and L. K. Basco. 1996. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaoundé, Cameroon. Am. J. Trop. Med. Hyg. 55:254-258.
29. van Vugt, M., A. Brockman, B. Gemperli, C. Luxemburger, I. Gathmann, C. Royce, T. Slight, S. Looareesuwan, N. J. White, and F. Nosten. 1998. Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. Antimicrob. Agents Chemother. 42:135-139.
30. von Seidlein, L., K. Bojang, P. Jones, S. Jaffar, M. Pinder, S. Obaro, T. Doherty, M. Haywood, G. Snounou, B. Gemperli, I. Gathmann, C. Royce, K. McAdam, and B. Greenwood. 1998. A randomized controlled trial of artemether/benflumetol, a new antimalarial, and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. Am. J. Trop. Med. Hyg. 58:638-644.
31. von Seidlein, L., S. Jaffar, M. Pinder, M. Haywood, G. Snounou, B. Gemperli, I. Gathmann, C. Royce, and B. Greenwood. 1997. Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697. J. Infect. Dis. 176:1113-1116.
32. Wernsdorfer, G., et al. 1996. XIVth International Congress for Tropical Medicine and Malaria, 17 to 22 November 1996, Nagasaki, Japan, abstr. O-22-8.
33. Wernsdorfer, W. H., et al. 1996. XIVth International Congress for Tropical Medicine and Malaria, 17 to 22 November 1996, Nagasaki, Japan, abstr. O-26-3.
34. Wernsdorfer, W. H., and D. Payne. 1991. The dynamics of drug resistance in Plasmodium falciparum. Pharmacol. Ther. 50:95-121.
35. World Health Organization. 1990. WHO technical report series, vol. 805. Practical chemotherapy of malaria. World Health Organization, Geneva, Switzerland.
36. Xiuquing, J., L. Guang-Yu, S. Cheng-Qi, Z. Xing, L. Xin Wei, I. Gathmann, and C. Royce. 1997. Phase II trial in China of a new, rapidly-acting and effective oral antimalarial, CGP 56697, for the treatment of Plasmodium falciparum malaria. Southeast Asian J. Trop. Med. Public Health 28:476-481.